Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3011% below fair value
$0.94−0.07 (-6.71%)
Close on Nov 20, 2026Market cap $94.41MP/E –Yield –
Stereotaxis shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Stereotaxis's shares outstanding was 100M at Jun 30, 2026. For fiscal 2025 it was 91M, up 6.8% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is 91M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 91M | +6.8% |
| FY2024 | Dec 31, 2024 | 85M | +5.6% |
| FY2023 | Dec 31, 2023 | 81M | +6.1% |
| FY2022 | Dec 31, 2022 | 76M | +0.7% |
| FY2021 | Dec 31, 2021 | 76M | +3.9% |
| FY2020 | Dec 31, 2020 | 73M | +15.4% |
| FY2019 | Dec 31, 2019 | 63M | +21.1% |
| FY2018 | Dec 31, 2018 | 52M | +130.3% |
| FY2017 | Dec 31, 2017 | 23M | +3.7% |
| FY2016 | Dec 31, 2016 | 22M | +3.3% |
| FY2015 | Dec 31, 2015 | 21M | +5.9% |
| FY2014 | Dec 31, 2014 | 20M | +72.6% |
| FY2013 | Dec 31, 2013 | 12M | +66.4% |
| FY2012 | Dec 31, 2012 | 7M | +26.7% |
| FY2011 | Dec 31, 2011 | 5M | +8.5% |
| FY2010 | Dec 31, 2010 | 5M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 100M | +13.7% |
| Q1 FY2026 | Mar 31, 2026 | 99M | +12.7% |
| Q4 FY2025 | Dec 31, 2025 | 96M | +10.6% |
| Q3 FY2025 | Sep 30, 2025 | 92M | +7.2% |
| Q2 FY2025 | Jun 30, 2025 | 88M | +4.0% |
| Q1 FY2025 | Mar 31, 2025 | 88M | +5.1% |
| Q4 FY2024 | Dec 31, 2024 | 87M | +5.0% |
| Q3 FY2024 | Sep 30, 2024 | 86M | +4.1% |
| Q2 FY2024 | Jun 30, 2024 | 85M | +4.3% |
| Q1 FY2024 | Mar 31, 2024 | 83M | +9.1% |
| Q4 FY2023 | Dec 31, 2023 | 83M | +8.4% |
| Q3 FY2023 | Sep 30, 2023 | 82M | +8.4% |
| Q2 FY2023 | Jun 30, 2023 | 81M | +6.7% |
| Q1 FY2023 | Mar 31, 2023 | 77M | +0.8% |
| Q4 FY2022 | Dec 31, 2022 | 76M | +0.7% |
| Q3 FY2022 | Sep 30, 2022 | 76M | +0.5% |
| Q2 FY2022 | Jun 30, 2022 | 76M | +0.5% |
| Q1 FY2022 | Mar 31, 2022 | 76M | +0.9% |
| Q4 FY2021 | Dec 31, 2021 | 76M | +1.1% |
| Q3 FY2021 | Sep 30, 2021 | 76M | +1.6% |
| Q2 FY2021 | Jun 30, 2021 | 76M | +5.5% |
| Q1 FY2021 | Mar 31, 2021 | 75M | +7.6% |
| Q4 FY2020 | Dec 31, 2020 | 75M | +10.3% |
| Q3 FY2020 | Sep 30, 2020 | 74M | +15.9% |
| Q2 FY2020 | Jun 30, 2020 | 72M | +19.3% |
| Q1 FY2020 | Mar 31, 2020 | 70M | +18.0% |
| Q4 FY2019 | Dec 31, 2019 | 68M | +15.0% |
| Q3 FY2019 | Sep 30, 2019 | 64M | +9.0% |
| Q2 FY2019 | Jun 30, 2019 | 60M | +1.9% |
| Q1 FY2019 | Mar 31, 2019 | 59M | +78.7% |
| Q4 FY2018 | Dec 31, 2018 | 59M | +159.3% |
| Q3 FY2018 | Sep 30, 2018 | 59M | +159.4% |
| Q2 FY2018 | Jun 30, 2018 | 59M | +161.0% |
| Q1 FY2018 | Mar 31, 2018 | 33M | +48.3% |
| Q4 FY2017 | Dec 31, 2017 | 23M | +3.9% |
| Q3 FY2017 | Sep 30, 2017 | 23M | +4.0% |
| Q2 FY2017 | Jun 30, 2017 | 23M | – |
| Q1 FY2017 | Mar 31, 2017 | 22M | – |
| Q4 FY2016 | Dec 31, 2016 | 22M | – |
| Q3 FY2016 | Sep 30, 2016 | 22M | – |
See a number that looks wrong?